PFE - Spark Newswire

1 minute read

Analyst Ratings

What 10 Analyst Ratings Have To Say About Pfizer

Today, 9:42 AM

Within the last quarter, Pfizer (NYSE:PFE) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish…

PFE

1 minute read

UBS Downgrades Pfizer to Neutral, Lowers Price Target to $47

By Benzinga Newsdesk

Today, 9:42 AM

UBS analyst Colin Bristow downgrades Pfizer (NYSE:PFE) from Buy to Neutral and lowers the price target from $55 to $47.

PFE

1 minute read

CDC Says Pfizer, BioNTech, Moderna’s Updated Bivalent COVID-19 Vaccines Helped Prevent Symptomatic Infections From XBB-Related Subvariants Of Omicron

By Michael Horton

Today, 9:42 AM

-Reuters

BNTX

1 minute read

COVID-19 Vaccine Strategy Might Follow The Influenza Shot Way, FDA To Decide Today

By Vandana Singh

Today, 9:42 AM

The FDA is considering a significant shift in the U.S.'s COVID-19 vaccine strategy to simplify vaccination against COVID-19.

BNTX

4 minute read

Google Layoffs 12K Employees, Netflix’s Q4 Earnings And CEO Steps Down, FDA Rejects Eli Lilly’s Alzheimer’s Candidate: Top Stories Friday, Jan. 20

By Vandana Singh

Today, 9:42 AM

Here's a round-up of stories from around the globe and from various media outlets. Benzinga

ABB

1 minute read

Israel Says No Stroke Risk Associated With Pfizer/BioNTech Updated COVID-19 Shots

By Vandana Singh

Today, 9:42 AM

Israel health ministry official said Isreal had not identified any evidence linking strokes to an updated coronavirus vaccine by Pfizer Inc (NYSE: PFE) and BioNTech SE (NASDAQ: BNTX).

BNTX

1 minute read

Analyst Views Novo Nordisk’s Upcoming Obesity Drug Data To Lay Grounds For Eli Lilly’s Tirzepatide

By Vandana Singh

Today, 9:42 AM

Cantor Fitzgerald published around 40-page deep dive ahead of Novo Nordisk A/S's (NYSE: NVO) SELECT CV outcomes study, which is guided to complete in ~mid-2023.

AMGN